You are here: Industry Insights > Acquisition

News List

AstraZeneca Receives US Clearance of Proposed Acquisition of Alexion americanpharmaceuticalreview
April 19, 2021
AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals, Inc (Alexion) has achieved an important step toward completion, having cleared US Federal Trade Commission review.
Amgen Completes Five Prime Acquisition contractpharma
April 19, 2021
Amgen has completed its acquisition of Five Prime Therapeutics for approximately $1.9 billion in cash. This acquisition adds Five Prime's innovative pipeline of immuno-oncology and targeted cancer therapies to Amgen's oncology portfolio.
Thermo Fisher Acquires PPD for $17.4B contractpharma
April 16, 2021
Thermo Fisher Scientific has acquired clinical research services provider PPD for $17.4 billion.
Cryoport Acquires Critical Transport Solutions Australia contractpharma
April 08, 2021
Cryoport, Inc., a global provider of temperature-controlled supply chain solutions for the life sciences, has acquired Critical Transport Solutions Australia Pty Ltd. (CTSA), a provider of healthcare logistics management services, for approximately ...
Sterling Pharma Solutions Acquires ADC Biotechnology contractpharma
April 08, 2021
Global contract development and manufacturing organization (CDMO), Sterling Pharma Solutions, has acquired ADC Biotechnology, a UK-based bioconjugation development services business specializing in antibody drug conjugates (ADCs).
Amneal completes acquisition of Kashiv Specialty Pharmaceuticals expresspharma
April 06, 2021
Kashiv Specialty Pharmaceuticals is focused on the development of complex generics, innovative drug delivery platforms and novel 505(b)(2) drugs.
Charles River Acquires Retrogenix contractpharma
April 06, 2021
Charles River Laboratories has acquired early-stage contract research organization (CRO) Retrogenix, a provider of specialized bioanalytical services utilizing its proprietary cell microarray technology, for $48 million.
Eloxx Pharmaceuticals Acquires Zikani Therapeutics contractpharma
April 02, 2021
Eloxx Pharmaceuticals, Inc. has acquired Zikani Therapeutics, Inc. in an all-stock transaction, combines complementary ribosomal RNA-targeted genetic therapy platforms and therapies for the treatment of rare diseases and oncology.
Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio contractpharma
April 02, 2021
Servier, a global pharmaceutical company, has successfully completed its acquisition of Agios Pharmaceuticals' commercial, clinical and research-stage oncology portfolio for up to $2 billion plus royalties.
Natco Pharma board okays acquiring 1 per cent in Canadian arm expresspharma
March 29, 2021
The board of directors of the company at their meeting approved to acquire 0.96 per cent stake in Natco Pharma Canada.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page